RaySearch Laboratories AB (publ) announces that Southwest Florida Proton, USA, has placed an order for the treatment planning system RayStation®* to be installed at its new proton center in Estero, Florida.
Southwest Florida Proton is establishing a proton center between Naples and Fort Myers, Florida, that will be the first cancer treatment center on Florida’s west coast to offer proton therapy, an effective treatment option for cancers of the brain and spine, breast, esophagus, head and neck, liver, lung, eye, pancreas and prostate, lymphoma, and soft tissue sarcomas. It is also considered standard of care when compared with conventional radiation for most pediatric indications. The center will be equipped with IBA’s Proteus One machine and the RayStation treatment planning system. RayStation is widely considered as the most advanced treatment planning system for proton therapy.
"Our team of physicians, investors and project partners searched worldwide to identify innovative technology that will truly redefine how cancer patients undergo treatments, now and into the future,” says Dr. Arie Dosoretz, a founding partner of Advocate Radiation Oncology and Southwest Florida Proton. “We chose to invest in RayStation because it is a product that allows us to unlock all the power that protons hold for effective cancer treatment.”
The RayStation configuration includes advanced technologies, including intensity modulated proton therapy, multi criteria optimization, Fallback planning for backup planning and modality comparisons, deformable registration, dose tracking, and adaptive therapy.
Johan Löf, founder and CEO, RaySearch, says: “RaySearch is the market leader in proton therapy planning, worldwide. The fact that proton delivery systems have become affordable to physician owned organizations is an exciting development, driven by the availability of single room solutions and increased clinical evidence supporting the use of protons. Supporting this widespread use, RayStation has the most advanced functionality of any product in the world, yet it remains accessible at every level. We look forward to supporting the South Florida Proton Center.”
The order was received and most of the revenue was recognized in Q2 2023.
About Southwest Florida Proton
Southwest Florida Proton in Estero will deliver top-tier cancer care to patients with a variety of cancers, including brain and spine, breast, esophagus, head and neck, liver, lung, eye, pancreas, and prostate, as well as lymphomas and soft tissue sarcomas. World-class, experienced doctors will use cutting-edge technology to provide top-tier care. Please visit SWFLproton.com for additional information.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch's software has been sold to over 900 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.
* Subject to regulatory clearance in some markets.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00